News

Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...
The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk ...
(Reuters) -Advisers to the U.S. Food and Drug Administration will discuss recommendations for updated COVID-19 vaccines ahead ...
The US Food and Drug Administration (FDA) announces new regulatory guidelines for future COVID-19 vaccines and booster shots.
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...
FDA FLAGS SEVERE ITCH — Patients who stop using the oral allergy medicines cetirizine (Zyrtec) or levocetirizine (Xyzal) may ...
Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.
FDA officials have warned the American public to not eat, sell or serve cucumbers grown and distributed by two Florida ...